Graphic announcing Synergy Spine Solutions attending EUROSPINE 2023
  • All
  • Executive Search
  • Finance
  • M&A
  • Views

Limited impact of the COVID-19 pandemic on the recurring operating result Upturn in activity beginning June 2020 Resumption of surgical operations seen in the 3rd quarter of 2020 Implanet is holding...

Acquisition includes lead clinical-stage compound AT-1501, a next generation anti-CD40L antibody, in development for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases Senior management team with extensive drug development and...